-
Innovation Ranking
NewInnovation Ranking – ARB Corporation Ltd
ARB Corporation Ltd (ARB) is a retailer of automobile parts and accessories. The company offers products such as protective equipment, vehicle lighting, old man emu 4x4 suspension, canopies and Ute lids, drawers and cargo barriers, roof racks and roof bars, long-range tanks, recovery equipment, air lockers and accessories, ARB compressors, camping accessories, portable fridge freezers; battery, power and 12V solar solutions and general accessories. It offers ARB compressors such as high output compressors, twin compressors, air locker activation systems and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabotamig in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabotamig in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabotamig in Gastric Cancer Drug Details: Cabotamig (ARB-202) is under development for...
-
Company Insights
Innovation and Patenting activity of ARB Corporation Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ARB Corporation Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARB-202 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARB-202 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ARB-202 in Pancreatic Cancer Drug Details:ARB-202 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARB-202 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARB-202 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ARB-202 in Colorectal Cancer Drug Details:ARB-202 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARB-202 in Gastrointestinal Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARB-202 in Gastrointestinal Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ARB-202 in Gastrointestinal TumorDrug Details:ARB-202 is under development for the treatment of refractory...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARB-202 in Metastatic Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARB-202 in Metastatic Liver Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ARB-202 in Metastatic Liver CancerDrug Details:ARB-202 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARB-202 in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARB-202 in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ARB-202 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details:ARB-202 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DA-5216 in Idiopathic (Essential) Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DA-5216 in Idiopathic (Essential) Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DA-5216 in Idiopathic (Essential) HypertensionDrug Details:DA-5216 is under development for the treatment...